Genequantum (Suzhou) Ltd is a high-tech biopharmaceutical company set up in August 2013, with a capital asset of 12million RMB. It is located in Suzhou Industrial Park and focused on the R&D of the next generation Biopharmaceuticals especially anticancer agents. Its core team are mainly from top research Institutes of Germany, United Kingdom and China, their major subjects cover biology, chemistry, pharmacology, quality control, as well as project management, business development, law and IP. Armed with their strong background and expertee, Genequantum is aiming to become a key player in the most competitive BioConjugation field.